Product Description: MRTX-1257 is a selective, irreversible, covalent and orally active KRAS G12C inhibitor, with an IC50 of 900 pM for KRAS dependent ERK phosphorylation in H358 cells[1].
Applications: Cancer-Kinase/protease
Formula: C33H39N7O2
References: [1]Matthew et al. Structure-Based Drug Discovery of MRTX1257, a Selective, Covalent KRAS G12C Inhibitor with Oral Activity in Animal Models of Cancer.
CAS Number: 2206736-04-9
Molecular Weight: 565.71
Compound Purity: 99.14
Research Area: Cancer
Solubility: DMSO : 55 mg/mL (ultrasonic)
Target: Ras